Evidence map›Paper›PMID 24056403›Full record

ArticleRadiology2014

Neural networks for nodal staging of non-small cell lung cancer with FDG PET and CT: importance of combining uptake values and sizes of nodes and primary tumor.

Lauren K Toney, Hubert J Vesselle

Abstract read
In one paragraph

Article in Radiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Lymph nodes rather than pleural metabolic activity inTranslational lung cancer research · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. [An Overview of the Application of Artificial Neural Networks in Lung Cancer Research].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2019
    Review
  14. A Prediction Model to Help with the Assessment of Adenopathy in Lung Cancer: HAL.American journal of respiratory and critical care medicine · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lauren K ToneyFrom the Division of Nuclear Medicine, Department of Radiology, University of Washington, 1959 NE Pacific St, RR-215, UW Mailbox 357115, Seattle, WA 98195-7115.
Hubert J Vesselle
University of Washington · US

Funding

THE BIOLOGY OF LUNG CANCER-- FDG AND FLUOROTHYMIDINE PETR01CA080907 · NCI · UNIVERSITY OF WASHINGTON · PI VESSELLE, HUBERT J · 2000 to 2004
$1.8M
NCI NIH HHS R01 CA080907
6 · The paper itself

Abstract

purposeTo evaluate the effect of adding lymph node size to three previously explored artificial neural network (ANN) input parameters (primary tumor maximum standardized uptake value or tumor uptake, tumor size, and nodal uptake at N1, N2, and N3 stations) in the structure of the ANN. The goal was to allow the resulting ANN structure to relate lymph node uptake for size to primary tumor uptake for size in the determination of the status of nodes as human readers do. MATERIALS AND

methodsThis prospective study was approved by the institutional review board, and informed consent was obtained from all participants. The authors developed a back-propagation ANN with one hidden layer and eight processing units. The data set used to train the network included node and tumor size and uptake from 133 patients with non-small cell lung cancer with surgically proved N status. Statistical analysis was performed with the paired t test.

resultsThe ANN correctly predicted the N stage in 99.2% of cases, compared with 72.4% for the expert reader (P < .001). In categorization of N0 and N1 versus N2 and N3 disease, the ANN performed with 99.2% accuracy versus 92.2% for the expert reader (P < .001).

conclusionThe ANN is 99.2% accurate in predicting surgical-pathologic nodal status with use of four fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT)-derived parameters. Malignant and benign inflammatory lymph nodes have overlapping appearances at FDG PET/CT but can be differentiated by ANNs when the crucial input of node size is used.

Indexed as

Neural Networks, ComputerAgedCarcinoma, Non-Small-Cell LungFemaleFluorodeoxyglucose F18HumansLung NeoplasmsLymph NodesMaleMiddle AgedNeoplasm StagingPositron-Emission TomographyPredictive Value of TestsPrognosisProspective StudiesRadiopharmaceuticalsFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID24056403
PMCPMC4228715
OpenAlexW2107613204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.